CAMBRIDGE, United Kingdom, April 29, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic ...
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results ...
Please provide your email address to receive an email when new articles are posted on . The patient received immunotherapy for squamous cell carcinoma. The patient was admitted for facial swelling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback